Merck Serono catch TOP1015 into the path analysis of 10 - Merck Serono - pharmaceutical industries
Century-old German Merck's global performance of the regional distribution of pie is quite beautiful, but it Should the day be able to show that China's share of the growth is even more perfect.
9 9, Merck Executive Board Chairman of Ke Lu Wei (Karl-LudwigKley) to access the machine through the Chinese media announced the first half of 2009 related to Merck's financial data: realized total revenue of 3.8 billion euros, while Over the past two years to complete integration of Merck Serono's contribution to the significant revenues of 2.622 billion euros, an increase of 8.4%.
China's performance is commendable, according to IMSHealth published data so far in 2009, Merck in China
Medicine Business growth among the top 15 largest pharmaceutical in China the first foreign-funded enterprises. This is a 58-year-old Ke Lu CD since 2007 after he takes office the second time the Chinese line. Last year, enjoy the complete unmatched Beijing Olympics, the only excited Lu Ke, saw and heard in China is determined to make him more convinced that Merck will be here as the focus of Asian business and global strategy, one of four core markets correctness. The past year, Merck's China strategy has been effectively implemented, and when he again visited given a report card?? September 8, Merck effect pigments to buy China's largest manufacturer of Suzhou baht Technology Development Corporation , completed the acquisition of its debut in China.
This is just the old company started investing in China. Ke Lu Wei said that Chinese medicine is the main business of Merck module, future drug development will become one of the key areas of investment. Merck is in China for 10 clinical studies and research projects will continue to expand in the coming years, to gradually bring China into its global R & D system, an important support department.
, Of course, have to rely on investment performance to match expected to do support. The reality is, with competitors, Merck Serono is a late person, to expectations by leading the Chinese to play a successful business in Asia, the focus of Merck's role, his team must do in this market to lead.
15 into the 10 path 8 18, the government long-awaited "National Essential Drugs List" issued, will be released immediately
Health Insurance Drugs catalog. Merck Serono is particularly concerned about this, its treatment of thyroid disease, drug match rule (Thyrozol) into the essential medicines list. In addition, the product line there are five kinds of drugs have been included in
Health Insurance Directory, and another part of the drugs into the part of the province of health insurance directory, enter the number of products are being adjusted to declare the new health insurance directory.
In general, access to opportunities and risks of drug use often co-exist directory. Opportunity is that a company can expand market coverage, increase
Sell Volume, but it also means that policy requirements may face downward pressure on prices. Obviously, for Merck Serono, the choice into the directory more in line with the current rapid growth in demand.
In fact, since 2007, Merck and Serono merger has been the rapid development of its China operations, the growth rate far exceeded the market average, multinational pharmaceutical companies in China's ranking jumped to 15, Merck & Snow Lander decided to win the put forward in the next 3 to 5 years to further improve the ranking the top 10 and become the "best" of the pharmaceutical companies.
Therefore "to maintain the current growth in the future will face greater challenges, the company now has basically covered the main business of large hospitals, but if the company is in clinical trials of drugs to pass registration, some have not yet entered medical insurance directory drugs can be included, then continue to maintain such a high growth rate is entirely possible. "Merck Serono Sui Cheng, general manager of China told reporters.
In order to achieve the "best" not only do the reasonable use policies, focus on maintenance and customer relationship between the medical profession and the Government is also an important part.
The e-commerce company in China offers quality products such as TG40 Diaphragm Wall Equipment , china Waterwell Drilling Rig, and more. For more , please visit Core Drilling Rig today!